These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 11642612)
21. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427 [TBL] [Abstract][Full Text] [Related]
22. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641 [TBL] [Abstract][Full Text] [Related]
23. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models. Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570 [TBL] [Abstract][Full Text] [Related]
24. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy. Kioi M; Takahashi S; Kawakami M; Kawakami K; Kreitman RJ; Puri RK Cancer Res; 2005 Sep; 65(18):8388-96. PubMed ID: 16166317 [TBL] [Abstract][Full Text] [Related]
25. Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy. Kawakami K; Kawakami M; Puri RK Crit Rev Immunol; 2001; 21(1-3):299-310. PubMed ID: 11642612 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy. Kawakami M; Kawakami K; Puri RK J Neurooncol; 2003 Oct; 65(1):15-25. PubMed ID: 14649882 [TBL] [Abstract][Full Text] [Related]
27. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527 [TBL] [Abstract][Full Text] [Related]
28. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy. Shimamura T; Husain SR; Puri RK Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016 [TBL] [Abstract][Full Text] [Related]
29. A review of studies on targeting interleukin 4 receptor for central nervous system malignancy. Puri S; Puri S; Mahapatra AK; Hussain E; Sarkar C; Sinha S; Joshi BH Curr Mol Med; 2009 Aug; 9(6):732-9. PubMed ID: 19689300 [TBL] [Abstract][Full Text] [Related]
30. An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link. Debinski W Crit Rev Oncog; 1998; 9(3-4):255-68. PubMed ID: 10201630 [TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. Husain SR; Puri RK J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884 [TBL] [Abstract][Full Text] [Related]
33. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]